Log In

Part Descriptions

LP14839-2   Plasmodium falciparum
Four species of the Plasmodium protozoa are considered true parasites of humans as they use humans almost exclusively as a natural intermediate host: P. falciparum, P. vivax, P. ovale and P. malariae. Malaria today is usually restricted to tropical and subtropical areas and altitudes below 1,500 m., although in the past malaria was endemic in much of North America, Europe and even parts of northern Asia, and today is still present on the Korean peninsula. However, this present distribution could be affected by climatic changes and population movements. P. falciparum is the most prevalent species and responsible for the most morbidity and mortality worldwide. Early detect is of paramount importance due to the incidence of cerebral malaria and drug resistance. Malarial infections caused by P. falciparum are the most likely to progress to severe, potentially fatal forms with central nervous system involvement (cerebral malaria), acute renal failure, severe anemia, or acute respiratory distress syndrome.[CDC] Source: Regenstrief LOINC, CDC

LP20149-8   Plasmodium
Malaria is a parasitic disease that is passed from one human to another by the bite of an infected Anopheles mosquito with one of four protozoan parasites: Plasmodium falciparum, vivax, malariae or ovale. The parasites enter the bloodstream and infect red blood cells where they multiply and infect more red blood cells. Symptoms usually occur 10 days to 4 weeks after infection and include anemia, high fevers, shaking chills, muscle pain, and nausea. Antimalarial agents used to treat malaria include Quinine, Quinidine, Mefloquine, Chloroquine, and Hydroxychloroquine. The effectiveness of the agents depends on which phase or phases of the Plasmodium life cycle is interrupted. In most cases, treatment outcome is expected to be good except in cases of a p. falciparum infection. Adverse effects from antimalaria medications include vomiting, diarrhea, headaches, cardiac arrhythmias, EKG abnormalities, deafness, damage to liver and kidney and muscle weakness. Source: NMS labs

LOINC Names Get Info

Fully-Specified Name
Plasmodium falciparum DNA:PrThr:Pt:Bld:Ord:Non-probe.amp.tar
Long Common Name
Plasmodium falciparum DNA [Presence] in Blood by NAA with non-probe detection
Short Name
P falciparum DNA Bld Ql NAA+n-prb
Display Name
P. falciparum DNA NAA+non-probe Ql (Bld)
Consumer Name Alpha Get Info
Plasmodium falciparum, Blood

Part Model Get Info

  • Component
    Plasmodium falciparum DNA
    LP39414-5
    • Analyte
      Plasmodium falciparum DNA
      LP39414-5
      • Component Numerator
        Plasmodium falciparum DNA
        LP39414-5
        • Component Numerator Core
          Plasmodium falciparum
          LP14839-2
        • Component Numerator Core Suffix
          DNA
          LP32416-7
      • Component Denominator
        NULL
         
        • Component Denominator Core
          NULL
           
        • Component Denominator Core Suffix
          NULL
           
    • Challenge
      NULL
       
    • Adjustment
      NULL
       
    • Count
      NULL
       
  • Property
    PrThr
    LP217195-9
  • Time
    Pt
    LP6960-1
  • System
    Bld
    LP7057-5
    • System Core
      Bld
      LP7057-5
    • Super System
      NULL
       
  • Scale
    Ord
    LP7751-3
  • Method
    Non-probe.amp.tar
    LP208998-7

Example Answer List: LL744-4

Source: Regenstrief Institute
AnswerCodeScoreAnswer ID
DetectedLA11882-0
Not detectedLA11883-8

Basic Attributes

Class
MICRO
Type
Laboratory
First Released
Version 2.74
Last Updated
Version 2.82 (MIN)
Order vs. Observation
Both

Member of these Panels

LOINCLong Common Name
101344-0Acute febrile illness global pathogens panel - Blood by NAA with non-probe detection

Member of these Groups Get Info

LOINC GroupGroup Name
LG41640-0Plasmodium

Language Variants Get Info

TagLanguageTranslation
cs-CZCzech (Czechia)Plasmodium falciparum DNA:Přítomnost nebo práh:Časový bod:Krev:Ordinální:Amplifikace nukleových kyselin s detekcí bez sondy
de-DEGerman (Germany)Plasmodium falciparum DNA:Nachweis oder Schwellenwert:Zeitpunkt:Blut:Ordinal:Zielfragmentamplifikation mit Detektion ohne Sonde
el-GRGreek (Greece)Πλασμώδιο falciparum DNA:PrThr:Pt:Αίμα:Ord:Χωρίς ανιχνευτή.ενίσχυση.στόχου
Synonyms: DNA MICRO Ord PrThr Pt Αίμα Ανιχνευτής Ανιχνευτής.ενίσχυση Ανιχνευτής.ενίσχυση.στόχου Πλασμώδιο falciparum Χωρίς ανιχνευτή.ενίσχυση.στόχου
es-ESSpanish (Spain)Plasmodium falciparum ADN:PrThr:Punto temporal:Sangre:Ord:Amplificación del objetivo no basado en sonda
fr-FRFrench (France)Plasmodium falciparum ADN:Présence/Seuil:Ponctuel:Sang:Qualitatif:Non-PCR amplification de cible
fr-CAFrench (Canada)Plasmodium falciparum, ADN:Présence-Seuil:Temps ponctuel:Sang:Ordinal:Non-sonde.amplification de cible
it-ITItalian (Italy)Plasmodium falciparum DNA:PrThr:Pt:Sangue:Ord:Non-sonda.amp.tar
Synonyms: Amplificazione target non basata su sonda Microbiologia Presenza o Soglia Punto nel tempo (episodio) Sangue Sonda con amplificazione Sonda con amplificazione del target Sonda di DNA
pl-PLPolish (Poland)Plasmodium falciparum DNA:granica wykrywalności:punkt w czasie:krew:uporządkowany:bez sondy.amplifikacja.cel
Synonyms: amplifikacja kwasu nukleinowego z detekcją bez użycia sondy amplifikacja kwasu nukleinowego z detekcją za pomocą sondy amplifikacja z detekcją za pomocą sondy Kwas deoksyrybonukleinowy Plasmodium falciparum
zh-CNChinese (China)恶性疟原虫 DNA:存在情况或阈值:时间点:全血:序数型:非探针法.基因扩增.靶向
Synonyms: 依次型;分类顺序型;定性的;序数型（或称等级型）;性质上的;有序型;有序性分类应答;有序性分类结果;秩次型;等级型;筛查;顺序型 借助扩增的探针方法;借助扩增的探针法;探针法.扩增 借助靶向扩增的探针方法;借助靶向扩增的探针法;探针法.扩增.靶向 借助靶向扩增的非探针方法;借助靶向扩增的非探针法;非探针法.扩增.靶向 原形体 原质团 去氧核糖核酸;脱氧核糖核酸 去氧核糖核酸;脱氧核糖核酸;脱氧核糖核酸（Deoxyribonucleic acid，DNA） 存在情况;存在;存在与否;是否存在;阈值;界值;界限;阀值;临界值;存在情况（存在、存在与否、是否存在）或阈值（界值、界限、阀值、临界值） 微生物学;微生物学试验;微生物学试验（培养、DNA、抗原及抗体） 恶性疟;热带疟原虫 扩增型 扩增性 时刻;随机;随意;瞬间 疟 疟原虫 疟疾 疟病 瘴气 经过扩增的 脱氧核糖核酸探针 血;血液

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=101306-9